Gayatri BioOrganics Ltd

Gayatri BioOrganics, a microcap chemicals company, reported flat performance in Q2 of fiscal year 2024-2025. However, concerns arise as cash and cash equivalents hit a low of Rs 0.03 crore and debtors turnover ratio reaches 0.00 times, indicating deteriorating liquidity and slower debt settlement. Operating profit margin also drops to -100.00%, affecting profitability. MarketsMOJO advises 'Sell' for the company's stock.

Gayatri BioOrganics, a microcap chemicals company, hit a 52-week low on April 2nd, 2024, prompting a 'Strong Sell' call by MarketsMOJO. The stock has been on a downward trend, underperforming the sector by -3.31% and trading below its moving averages. With a decline of -33.75% in the past year, investors should carefully consider before investing.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently seen a decline in its stock price, reaching a 52-week low of Rs 4.95 on April 1st, 2024. According to financial analysis platform MarketsMOJO, the stock is currently a 'Strong Sell' due to underperformance and trading below moving averages. The company's 1-year performance is -31.66%, highlighting its struggles in the market. Investors should carefully consider their decisions.

Gayatri BioOrganics, a microcap company in the chemicals industry, has hit a 52-week low on March 28, 2024, causing concern among investors. The stock price has decreased significantly and is currently trading below all moving averages. In comparison to the Sensex, the company has shown a negative performance, highlighting its struggles in the market.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently hit a 52-week low on March 22, 2024, causing concern among investors. The stock has been on a downward trend, trading below all moving averages and underperforming the Sensex by -36.71% in the past year. A Strong Sell rating by MarketsMOJO suggests caution for potential investors.

Gayatri BioOrganics, a microcap company in the chemicals industry, has hit a 52-week low on March 15, 2024, prompting a 'Strong Sell' call from MarketsMOJO. The stock has underperformed the sector by -3.79% and is currently trading below its moving averages. In the past year, the stock has declined by -38.32%, highlighting the challenges faced by the company in the competitive market. Investors should carefully assess the company's financials and market conditions before investing.

Gayatri BioOrganics, a microcap company in the chemicals industry, has seen a dip in its stock price, hitting a 52-week low on March 14, 2024. The stock has been given a 'Strong Sell' rating by MarketsMOJO and has underperformed the sector by -2.16%. It is currently trading below its moving averages and has experienced a significant decline compared to the Sensex. Investors should closely monitor the company's financial performance and industry developments before making any investment decisions.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently hit a 52-week low of Rs. 5.45 on February 22, 2024, leading to a 'Strong Sell' call by MarketsMOJO. The stock has been trading below its moving averages and has seen a decline of -14.47% in the past year, underperforming the overall market. However, there is a slight uptick in the stock's performance after 10 consecutive days of falling, which could potentially indicate a trend reversal in the near future. It is important to conduct thorough research and seek professional advice before making any investment decisions.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently hit a 52-week low of Rs. 5.7 on February 21, 2024. This has resulted in a 'Strong Sell' call by MarketsMOJO, indicating potential underlying issues affecting the company's financials. Investors should exercise caution and conduct their own research before investing.

Gayatri BioOrganics, a microcap chemicals company, has seen a dip in its stock price, hitting a 52-week low of Rs. 5.72 on February 20, 2024. MarketsMOJO has given a 'Strong Sell' call. The stock has underperformed the sector by -5.32% and has been on a downward trend for 9 days with a -28.86% decrease in returns. It is currently trading below its moving averages and has experienced a -21.54% decline compared to Sensex's 20.37% increase in the past year. Investors should be cautious due to the company's susceptibility to market fluctuations.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently experienced a decline in its stock price, hitting a 52-week low on February 19, 2024. According to MarketsMOJO, the stock has been given a Strong Sell rating and is currently trading below its moving averages. In comparison to the overall market, the company has underperformed, highlighting the challenges it faces in the current market conditions. Investors should carefully consider all available information before making any investment decisions.

Gayatri BioOrganics, a microcap company in the chemicals industry, has seen a significant drop in its stock price, hitting a 52-week low of Rs. 5.91 on February 16, 2024. MarketsMOJO has issued a 'Strong Sell' call for the stock, which has underperformed the sector and market in the past year. The company remains committed to its mission and is working towards improving its performance.

Gayatri BioOrganics, a microcap company in the chemicals industry, has recently seen a dip in its stock price, reaching a 52-week low on February 15, 2024. According to MarketsMOJO, the stock is currently a 'Strong Sell' due to its underperformance and market trends. It has shown a slight increase today, but is still trading below its moving averages. Compared to the Sensex, the company has experienced a negative performance, highlighting its struggles in the market. Investors should carefully consider their options as the company works towards improving its performance.

Gayatri BioOrganics, a microcap chemicals company, reported a flat performance in the quarter ending December 2023 with a Strong Sell rating from MarketsMOJO. However, the company's Debtors Turnover Ratio has been the highest in the last five half-yearly periods, indicating efficient collection of payments from debtors. Investors should conduct their own research before investing.

Gayatri BioOrganics, a microcap chemicals company, reported a 45% increase in standalone net profit and a 52.94% rise in operating profit for the quarter ended September 2023. However, interest expenses also saw a significant increase. Despite improved financial score and positive developments, the stock call is currently 'Strong Sell' due to challenges in net sales and operating profit margin.